Performance Report And Forecasts For Ovid Therapeutics Inc (NASDAQ: OVID)

In the latest trading session,, 2.04 million Ovid Therapeutics Inc (NASDAQ:OVID) shares changed hands as the company’s beta touched 0.42. With the company’s most recent per share price at $0.84 changing hands around $0.05 or 6.88% at last look, the market valuation stands at $59.87M. OVID’s current price is a discount, trading about -392.86% off its 52-week high of $4.14. The share price had its 52-week low at $0.75, which suggests the last value was 10.71% up since then. When we look at Ovid Therapeutics Inc’s average trading volume, we note the 3-month average coming to 529.04K.

Ovid Therapeutics Inc (NASDAQ:OVID) trade information

Instantly OVID is in green as seen in intraday trades today. With action -72.86%, the performance over the past five days has been red. The jump to weekly highs of 3.3100 added 6.88% to the stock’s daily price. The company’s shares are showing year-to-date downside of -73.79%, with the 5-day performance at -72.86% in the red. However, in the 30-day time frame, Ovid Therapeutics Inc (NASDAQ:OVID) is -73.21% down.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Ovid Therapeutics Inc (OVID) estimates and forecasts

Data shows that the Ovid Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -75.47% over the past 6 months, a -14.86% in annual growth rate that is considerably lower than the industry average of 15.60%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 18.87%. The 2024 estimates are for Ovid Therapeutics Inc earnings to decrease by -11.45%.